🔎 Trials Near Me

Akèy › Ipètansyon atè pulmonè › Maryland

Etid klinik pou Ipètansyon atè pulmonè nan Maryland

5 etid pou Ipètansyon atè pulmonè ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

Spironolactone for Pulmonary Arterial Hypertension

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01712620

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT07613099

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

  • The Johns Hopkins Hospital, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT06992440

Pulmonary Hypertension Association Registry

  • University of MD Medical Group, PA, Baltimore
  • Johns Hopkins University, Baltimore
Ap rekriteEtid obsèvasyon
Laj 0 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT04071327

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

  • Johns Hopkins Children's Center, Baltimore
Ap rekriteEtid obsèvasyon
1 Day – 21 Years · Tout sèks · Mizajou Mar 13, 2025 · NCT02249923

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.